TickerFacts.

Vivos Inc (RDGL): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.66M
As of 2025-12-31
$2.76M
As of 2026-06-30
0.0%
3-year compound annual growth
n/m
5-year compound annual growth
$2.15M2010-12-31: -$2.96M2011-12-31: -$4.84M2012-12-31: -$9.85M2013-12-31: -$8.97M2014-12-31: -$20.16M2015-12-31: -$14.33M2016-12-31: -$3.02M2017-12-31: -$4.26M2018-03-31: -$5.09M2018-06-30: -$10.67M2018-09-30: -$34.70M2018-12-31: -$942.2K2019-03-31: -$1.05M2019-06-30: -$1.23M2019-09-30: -$1.19M2019-12-31: -$1.48M2020-12-31: $32.0K2021-12-31: $1.47M2022-12-31: $1.66M2023-12-31: $1.37M2024-12-31: $2.15M2025-12-31: $1.66M$1.66M
2010-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$1.66M-22.7%2026-03-31, Balance as of period end
2024-12-31$2.15M+57.3%2026-03-31, Balance as of period end
2023-12-31$1.37M-17.8%2025-03-24, Balance as of period end
2022-12-31$1.66M+13.2%2024-03-18, Balance as of period end
2021-12-31$1.47Mn/m2023-03-01, Balance as of period end
2020-12-31$32.0Kn/m2022-03-07, Balance as of period end
2019-12-31-$1.48Mn/a2021-03-24, Balance as of period end
2019-09-30-$1.19Mn/a2020-04-28, Balance as of period end
2019-06-30-$1.23Mn/a2020-04-28, Balance as of period end
2019-03-31-$1.05Mn/a2020-04-28, Balance as of period end
2018-12-31-$942.2Kn/a2020-04-28, Balance as of period end
2018-09-30-$34.70Mn/a2020-04-28, Balance as of period end
2018-06-30-$10.67Mn/a2020-04-28, Balance as of period end
2018-03-31-$5.09Mn/a2020-04-28, Balance as of period end
2017-12-31-$4.26Mn/m2019-03-25, Balance as of period end
2016-12-31-$3.02Mn/c2018-04-02, Balance as of period end
2015-12-31-$14.33Mn/m2018-01-25, Balance as of period end
2014-12-31-$20.16Mn/m2016-05-26, Balance as of period end
2013-12-31-$8.97Mn/m2015-04-21, Balance as of period end
2012-12-31-$9.85Mn/m2014-03-31, Balance as of period end
2011-12-31-$4.84Mn/m2013-03-29, Balance as of period end
2010-12-31-$2.96Mn/a2012-03-23, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Vivos Inc (RDGL)2025-12-31$1.66M-22.7%
Family Office of America, Inc. (FOFA)2025-12-31$664.5Kn/m
QTREX Quantum Ltd. (QTEX)2025-12-31$2.32M-46.3%
Pulse Biosciences, Inc. (PLSE)2025-12-31$80.66M-29.8%
Co-Diagnostics, Inc. (CODX)2025-12-31$20.63M-61.7%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$1.06M-67.2%
Flyte Aviation, Inc. (VJET)2025-12-31$7.05M-40.0%
Sintx Technologies, Inc. (SINT)2025-12-31$2.93M-24.8%
RenovoRx, Inc. (RNXT)2025-12-31$5.42M+21.1%

Compare RDGL, FOFA, QTEX, PLSE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗